Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
IRONWOOD PHARMACEUTICALS INC (IRWD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| Silver Ronald (Principal Accounting Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 1,976 shares
@ $10.04, valued at
$19.8k
|
|
| 08/16/2023 |
4
| John Minardo (Chief Legal Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 7,045 shares
@ $10.04, valued at
$70.7k
|
|
| 06/01/2023 |
4
| MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 26,632 shares
@ $10.7, valued at
$285k
|
|
| 05/24/2023 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 10,324 shares
@ $10.12, valued at
$104.5k
|
|
| 05/24/2023 |
4
| Davis Andrew (SVP, Chief Business Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 6,305 shares
@ $10.12, valued at
$63.8k
|
|
| 05/24/2023 |
4
| MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 36,000 shares
@ $10.12, valued at
$364.3k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Moukheibir Catherine (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 1,677 shares
@ $0 |
|
| 03/17/2023 |
4
| DENNER ALEXANDER J (10% Owner) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 1,438 shares
@ $0 |
|
| 03/10/2023 |
4
| Silver Ronald (Principal Accounting Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 35,620 shares
@ $0 |
|
| 03/10/2023 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 69,869 shares
@ $0
Granted 34,935 options to buy
@ $0 |
|
| 03/10/2023 |
4
| Rickard Jason (SVP, COO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 43,668 shares
@ $0
Granted 21,834 options to buy
@ $0 |
|
| 03/10/2023 |
4
| John Minardo (Chief Legal Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 65,502 shares
@ $0
Granted 32,751 options to buy
@ $0 |
|
| 03/10/2023 |
4
| MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 240,595 shares
@ $0
Granted 120,297 options to buy
@ $0 |
|
| 03/10/2023 |
4
| Emany Sravan Kumar (SVP, CFO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 74,236 shares
@ $0
Granted 37,118 options to buy
@ $0 |
|
| 03/10/2023 |
4
| Davis Andrew (SVP, Chief Business Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 74,236 shares
@ $0
Granted 37,118 options to buy
@ $0 |
|
| 03/07/2023 |
4
| MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 33,756 shares
@ $11.22, valued at
$378.7k
|
|
| 03/01/2023 |
4
| Silver Ronald (Principal Accounting Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 2,929 shares
@ $11.41, valued at
$33.4k
Sold 3,049 shares
@ $11.31, valued at
$34.5k
|
|
| 03/01/2023 |
4
| Rickard Jason (SVP, COO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 13,438 shares
@ $11.41, valued at
$153.3k
Sold 3,308 shares
@ $11.41, valued at
$37.7k
Sold 13,987 shares
@ $11.31, valued at
$158.2k
Sold 3,442 shares
@ $11.31, valued at
$38.9k
|
|
| 03/01/2023 |
4
| MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 25,595 shares
@ $11.41, valued at
$292k
Sold 4,409 shares
@ $11.41, valued at
$50.3k
Sold 26,639 shares
@ $11.31, valued at
$301.3k
Sold 4,588 shares
@ $11.31, valued at
$51.9k
|
|
| 03/01/2023 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 7,146 shares
@ $11.41, valued at
$81.5k
Sold 2,322 shares
@ $11.41, valued at
$26.5k
Sold 7,438 shares
@ $11.31, valued at
$84.1k
Sold 2,416 shares
@ $11.31, valued at
$27.3k
|
|
| 03/01/2023 |
4
| John Minardo (Chief Legal Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 3,282 shares
@ $11.41, valued at
$37.4k
Sold 3,415 shares
@ $11.31, valued at
$38.6k
|
|
| 03/01/2023 |
4
| Davis Andrew (SVP, Chief Business Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 1,751 shares
@ $11.41, valued at
$20k
Sold 1,822 shares
@ $11.31, valued at
$20.6k
|
|
| 01/19/2023 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 14,663 shares
@ $0 |
|
| 01/19/2023 |
4
| Rickard Jason (SVP, COO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 18,087 shares
@ $0 |
|
| 01/19/2023 |
4
| MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 30,145 shares
@ $0 |
|
| 01/09/2023 |
4
| MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 110,962 shares
@ $12.07, valued at
$1.3M
Exercised 110,962 options to buy
@ $11.65, valued at
$1.3M
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 18,899 shares
@ $10.41, valued at
$196.7k
|
|
| 09/19/2022 |
4
| DENNER ALEXANDER J (10% Owner) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 1,374 shares
@ $0 |
|
|
|
|